Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging
Feng Chen,Xiuli Zhang,Kai Ma,Brian Madajewski,Miriam Benezra,Li Zhang,Evan Phillips,Melik Z. Turkey,Fabio Gallazzi,Oula Penate-Medina,Michael Overholtzer,Mohan Pauliah,Mithat Gonen,Pat Zanzonico,Ulrich Wiesner,Michelle S. Bradbury,Thomas P. Quinn
DOI: https://doi.org/10.1021/acsami.7b14362
IF: 9.5
2017-01-01
ACS Applied Materials & Interfaces
Abstract:The poor prognosis associated with, malignant melanoma has not changed substantially over the past 30 years. Targeted molecular therapies, such as imniunotherapy, have shown promise but suffer from resistance and off-target toxicities, underscoring the need for alternative therapeutic strategies that can be used in combination with existing protocols. Moreover, peptides targeting melanoma-specific walkers, like the melanocortin-1 receptor (MC1-R), for imaging and therapy exhibit high renal uptake that limits clinical translation. In the current study, the application of tiltrasmall fluorescent (Cy5) silica nanoparticles (C' dots), conjugated with MC1-R targeting, alpha melanocyte stimulating hormone (alpha MSH) peptides on the polyethylene glycol (PEG) coated surface, is ekamined for melanoma-selective imaging. aMSH peptide sequences, evaluated for conjugation to the PEG-Cy5-C' dot nanoparticles, bound to MC1-R with high affinity and targeted melanoma in syngenetic and xenografted melanoma mouse models. Results demonstrated a 10-fold improvement in MC1-R affinity over the native peptide alone following surface attachment of the optimal aMSH peptide. Systematic in vivo studies further demonstrated favorable in vivo renal clearance kinetics as well as receptor-mediated tumor cell internalization of as-developed radiolabdecIparticle tracers in B16F10 melanoma bearing mice. These findings highlight the ability of alpha MSH-PEG-Cy5-C' dots to overcome previous hurdles that prevented clinical translation of peptide and antibody-based melanoma probes and reveal the potential of alpha MSH-PEG-Cy5-C' dots for melanoma-selective imaging, image-guided surgery, and therapeutic applications.